health canada approval zepbound tirzepatide obesity canada 2024 2025 Pharmacotherapy for management in adults: CPG update webinar Eli Lilly cuts Zepbound price

It decreases the peristaltic activity of the stomach that helps move food forward, resulting in decreased gastric emptying

The medication is building up in your system

Since compounded therapies come directly from a pharmacy, their out-of-pocket cost is almost always less than the commercial medication which comes from big pharmaceutical companies

It contributes to early satiety and weight loss, but also underlies many of the adverse effects and emergency department presentations associated with these medications

Clinical guidelines for FDA-approved GLP-1/GIP therapies generally include adults with obesity (BMI 30) or overweight (BMI 27) with weight-related conditions such as type 2 diabetes or high blood pressure

This is especially important for researchers working with compounded or lyophilized formulations where waste from expired medication can be significant